PetVivo achieved a significant milestone – surpassing 4500 syringes of Spryng with OsteoCushion technology distributed to veterinarians in the 2023 calendar year. Thanks to the support of veterinarians throughout the United States, Spryng has experienced strong momentum this year, driven by the beneficial outcomes experienced by thousands of animals injected with this life changing product. “Achieving this distribution milestone involving Spryng is a testament to the unwavering support of the veterinarian community and their passion to help animals suffering from debilitating lameness related diseases, such as osteoarthritis,” said John Lai, Chief Executive Officer of PetVivo Holdings, Inc. “We’re grateful for all the veterinarians who have added Spryng to their toolbox of therapeutics and medical devices, and we’re thrilled that we are witnessing the positive impact Spryng has had in helping animals suffering from joint related afflictions.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on PETV:
- PetVivo Holdings, Inc. Achieves Distribution Milestone Surpassing 4500 Syringes of Spryng™ in 2023
- PetVivo achieves national distribution of Spryng to over 600 vet clinics
- PetVivo Holdings, Inc. Achieves National Distribution of Spryng™ to More than 600 Veterinary Clinics in 49 States
- PetVivo Holdings, Inc. to Exhibit at American Association of Equine Practitioners Conference in San Diego, California
- PetVivo Reports Second Quarter of Fiscal 2024 Financial Results